Press "Enter" to skip to content

: FDA advisers narrowly back accelerated approval of Sarepta gene therapy

http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71F4-CFDE0BD1906E%7D&siteid=rss&rss=1
FDA advisers vote 8-6 Friday to recommend the agency grant accelerated approval to Sarepta Therapeutics Inc.’s gene therapy for Duchenne muscular dystrophy…

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »